568
Views
26
CrossRef citations to date
0
Altmetric
Review

Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma

&
Pages 1867-1878 | Accepted 07 Jun 2007, Published online: 29 Jun 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Timothy E. Albertson, Janelle V. Pugashetti, Florence Chau-Etchepare, James A. Chenoweth & Susan Murin. (2020) Pharmacotherapeutic management of asthma in the elderly patient. Expert Opinion on Pharmacotherapy 21:16, pages 1991-2010.
Read now
Xin Ye, Benjamin Gutierrez, Victoria Zarotsky, Michael Nelson & Christopher M. Blanchette. (2009) Appropriate use of inhaled corticosteroid and long-acting ß2-adrenergic agonist combination therapy among asthma patients in a US commercially insured population. Current Medical Research and Opinion 25:9, pages 2251-2258.
Read now

Articles from other publishers (24)

Juan Carlos Cardet, Alberto Papi & Helen K. Reddel. (2023) “As-Needed” Inhaled Corticosteroids for Patients With Asthma. The Journal of Allergy and Clinical Immunology: In Practice 11:3, pages 726-734.
Crossref
Dongjie Wang, Wen Li, Natalie Albasha, Lindsey Griffin, Han Chang, Lauren Amaya, Sneha Ganguly, Liping Zeng, Bora Keum, José M. González-Navajas, Matt Levin, Zohreh AkhavanAghdam, Helen Snyder, David Schwartz, Ailin Tao, Laela M. Boosherhri, Hal M. Hoffman, Michael Rose, Monica Valeria Estrada, Nissi Varki, Scott Herdman, Maripat Corr, Nicholas J. G. Webster, Eyal Raz & Samuel Bertin. (2023) Long-term exposure to house dust mites accelerates lung cancer development in mice. Journal of Experimental & Clinical Cancer Research 42:1.
Crossref
Iain Crossingham, Sally Turner, Sanjay Ramakrishnan, Anastasia Fries, Matthew Gowell, Farhat Yasmin, Rebekah Richardson, Philip Webb, Emily O'Boyle & Timothy SC Hinks. (2021) Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma. Cochrane Database of Systematic Reviews 2021:5.
Crossref
Marek Kokot. (2017) Leczenie astmy, dziś i jutro – perspektywa osobista. Alergologia Polska - Polish Journal of Allergology 4:1, pages 20-24.
Crossref
Mark L Levy, P N R Dekhuijzen, P J Barnes, M Broeders, C J Corrigan, B L Chawes, L Corbetta, J C Dubus, Th Hausen, F Lavorini, N Roche, J Sanchis, Omar S Usmani, J Viejo, W Vincken, Th Voshaar, G K Crompton & Soren Pedersen. (2016) Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT). npj Primary Care Respiratory Medicine 26:1.
Crossref
John Gar Yan Chan, Jennifer Wong, Qi Tony Zhou, Sharon Shui Yee Leung & Hak-Kim Chan. (2014) Advances in Device and Formulation Technologies for Pulmonary Drug Delivery. AAPS PharmSciTech 15:4, pages 882-897.
Crossref
Nanshan Zhong, Jiangtao Lin, Parthiv Mehta, Pintip Ngamjanyaporn, Tzu-Chin Wu & Faisal Yunus. (2013) Real-life effectiveness of budesonide/formoterol maintenance and reliever therapy in asthma patients across Asia: SMARTASIA study. BMC Pulmonary Medicine 13:1.
Crossref
Christopher J Cates & Charlotta Karner. (2013) Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children. Cochrane Database of Systematic Reviews 2016:7.
Crossref
Christopher J Cates, Roman Jaeschke, Stefanie Schmidt & Montse Ferrer. (2013) Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database of Systematic Reviews.
Crossref
Sae-Hoon KimSang-Heon Cho. (2012) Educational and decision-support tools for asthma-management guideline implementation. Asia Pacific Allergy 2:1, pages 26.
Crossref
Stephanie Korn & Roland Buhl. (2012) Efficacy of a fixed combination of ciclesonide and formoterol: The EXCITED-study. Respiratory Medicine 106:1, pages 57-67.
Crossref
Janet M. Davies, Melanie L. Carroll, Hongzhuo Li, Alisa M. Poh, Darren Kirkegard, Michelle Towers & John W. Upham. (2011) Budesonide and Formoterol Reduce Early Innate Anti-Viral Immune Responses In Vitro. PLoS ONE 6:11, pages e27898.
Crossref
Michel Aubier, John Haughney, Olof Selroos, Onno C. P. van Schayck, Tommy Ekström, Juliette Ostinelli & Roland Buhl. (2011) Is the patient’s baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?. Therapeutic Advances in Respiratory Disease 5:5, pages 289-298.
Crossref
Alan Kaplan & Dermot Ryan. (2010) The role of budesonide/formoterol for maintenance and relief in the management of asthma. Pulmonary Pharmacology & Therapeutics 23:2, pages 88-96.
Crossref
Klaus J. Erb, Domnic H. Martyres & Peter Seither. 2003. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry.
Christopher M. Blanchette, Steven D. Culler, Daniel Ershoff & Benjamin Gutierrez. (2009) Association between previous health care use and initiation of inhaled corticosteroid and long-acting β2-adrenergic agonist combination therapy among US patients with asthma. Clinical Therapeutics 31:11, pages 2574-2583.
Crossref
V. Backer, H. Nolte, L. Pedersen, N. Dam & H. Harving. (2009) Unawareness and undertreatment of asthma: follow-up in a different geographic area in Denmark. Allergy 64:8, pages 1179-1184.
Crossref
Christopher J Cates, Toby J Lasserson & Roman Jaeschke. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Christopher J Cates & Toby J Lasserson. (2009) Combination formoterol and inhaled steroid versus beta 2 -agonist as relief medication for chronic asthma in adults and children . Cochrane Database of Systematic Reviews.
Crossref
Leif Bjermer & Zuzana Diamant. (2009) Complementary therapy in asthma: inhaled corticosteroids and what?. Current Opinion in Pulmonary Medicine 15:1, pages 46-51.
Crossref
Malcolm R. Sears. (2009) Step-up therapy in uncontrolled asthma: Choices and outcomes. Journal of Allergy and Clinical Immunology 123:1, pages 122-123.
Crossref
M. Humbert, T. L. G. Andersson & R. Buhl. (2008) Budesonide/formoterol for maintenance and reliever therapy in the management of moderate to severe asthma. Allergy 63:12, pages 1567-1580.
Crossref
. (2008) Current World Literature. Current Opinion in Allergy & Clinical Immunology 8:3, pages 276-285.
Crossref
M A Giembycz, M Kaur, R Leigh & R Newton. (2008) A Holy Grail of asthma management: toward understanding how long-acting β 2 -adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids . British Journal of Pharmacology 153:6, pages 1090-1104.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.